Stay updated with breaking news from Professor ooi eng. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Potential COVID-19 antibody drug made by Singapore firm to be tested on 1,305 local, overseas patients Toggle share menu Advertisement Potential COVID-19 antibody drug made by Singapore firm to be tested on 1,305 local, overseas patients Advertisement Singapore Potential COVID-19 antibody drug made by Singapore firm to be tested on 1,305 local, overseas patients Prof Ooi Eng Eong is also a co-founder of biotechnology company Tychan, which developed the world’s first Zika antibody in nine months. (Photo: Tychan) 11 Dec 2020 12:10PM) Share this content Bookmark SINGAPORE: A potential COVID-19 antibody drug developed by a Singapore-based company will be tested on 1,305 infected patients locally and abroad, in what would be its final trial before it can be approved for treatment in Singapore. ....